The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC
2.
Modified personalized cancer vaccine generates powerful immune response
3.
Advanced Solid Tumors May Benefit from Investigative Immunotherapy Combo.
4.
Congress Ditched Fix to Medicare Doc Pay Cut in Skinny Budget Bill
5.
Patients value communication skills from cancer surgeons across six key areas, according to research
1.
The Statistical Frontier of Hematology Oncology: Diagnostics, Therapies, and Future Horizons in Hematology Oncology 2025
2.
Uncovering Breast Cancer: The Power of Early Stage Ultrasound
3.
Understanding Protein C Deficiency: Symptoms, Causes, and Treatment
4.
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
5.
Targeted Therapies for Breast Cancer: What’s New?
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion
3.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
4.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
5.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation